17.04.2019 17:36:00

Catalent Pharma Solutions, Inc. -- Moody's: Catalent's acquisition of Paragon will increase leverage, a credit negative

Announcement: Moody's: Catalent's acquisition of Paragon will increase leverage, a credit negative

Vollständigen Artikel bei Moodys lesen